The TGA has previously been cautious about approving over-the-counter tests for personal use, such as the ones developed by Ellume, but it has been more positive about tests such as AnteoTechs EuGeni test, which are designed to be used in a mass-screening setting by a trained operator.
AnteoTech CEO Derek Thomson said the company were just starting the TGA approval process, meaning any approvals would likely be granted next year at the earliest even with an accelerated timeframe.
Mr Thompson said…
Local made rapid COVID test launches in EU, seeks Australian approval – Brisbane Times
- Advertisement -
- Advertisment -

